[Immunosuppressive agents].
D000305:Adrenal Cortex Hormones / Q000145:classification; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D000961:Antilymphocyte Serum / Q000145:classification; D000970:Antineoplastic Agents / Q000145:classification; D001167:Arteritis / Q000188:drug therapy; D001528:Behcet Syndrome / Q000188:drug therapy; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D013700:Giant Cell Arteritis / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D010392:Pemphigus / Q000188:drug therapy; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011711:Pyoderma / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012859:Sjogren's Syndrome / Q000188:drug therapy; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents
Immunsuppressiva.